Intravesical thermo-chemotherapy based on conductive heat: a first pharmacokinetic study with Mitomycin C in superficial transitional cell carcinoma patients-Reference-Cited by-同舟云学术

Intravesical thermo-chemotherapy based on conductive heat: a first pharmacokinetic study with Mitomycin C in superficial transitional cell carcinoma patients

Published:2014-01-18 Issue:3 Volume:73 Page:503-509
ISSN:0344-5704
Container-title:Cancer Chemotherapy and Pharmacology
language:en
Short-container-title:Cancer Chemother Pharmacol

Author:

Milla Paola,Fiorito Chiara,Soria Francesco,Arpicco Silvia,Cattel Luigi,Gontero Paolo

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s00280-014-2381-4.pdf

Reference26 articles.

1. Epstein JI, Amin MB, Reuter VR, Mostofi FK (1998) The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Bladder Consensus Conference Committee. Am J Surg Pathol 22(12):1435–1448

2. Vogeli TA (2005) The management of superficial transitional cell carcinoma of the bladder: a critical assessment of contemporary concepts and future perspectives. BJU Int 96(8):1171–1176. doi: 10.1111/j.1464-410X.2005.05928.x

3. Witjes JA, Hendricksen K (2008) Intravesical pharmacotherapy for non-muscle-invasive bladder cancer: a critical analysis of currently available drugs, treatment schedules, and long-term results. Eur Urol 53(1):45–52. doi: 10.1016/j.eururo.2007.08.015

4. Kaufman DS, Shipley WU, Feldman AS (2009) Bladder cancer. Lancet 374(9685):239–249. doi: 10.1016/S0140-6736(09)60491-8

5. Shelley MD, Mason MD, Kynaston H (2010) Intravesical therapy for superficial bladder cancer: a systematic review of randomised trials and meta-analyses. Cancer Treat Rev 36(3):195–205. doi: 10.1016/j.ctrv.2009.12.005

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The effect of intravesical chemohyperthermia with mitomycin in non-muscle-invasive bladder tumour patients who cannot tolerate BCG treatment or recur after treatment and refuse cystectomy;International Urology and Nephrology;2024-07-31

2. Re: Wei Shen Tan, Aaron Prendergast, Charlotte Ackermann, et al. Adjuvant Intravesical Chemohyperthermia Versus Passive Chemotherapy in Patients with Intermediate-risk Non–muscle-invasive Bladder Cancer (HIVEC-II): A Phase 2, Open-label, Randomised Controlled Trial. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2022.08.003;European Urology;2023-02

3. In vitro anticancer evaluation of Enceleamycin A and its underlying mechanism;RSC Advances;2023

4. A scalable hyperthermic intravesical chemotherapy (HIVEC) setup for rat models of bladder cancer;Scientific Reports;2022-04-29

5. Tratamientos actuales tras fracaso a BCG en cáncer de vejiga no músculo-invasivo;Actas Urológicas Españolas;2021-03